https://healthcarewiretexas.com/article/915134472-american-society-of-radiologic-technologists-and-tether-supervision-partner-to-develop-contrast-management-series Healthcare Wire Texas en PressRelease 2026-05-26T13:00:00+00:00 American Society of Radiologic Technologists and Tether Supervision Partner to Develop Contrast Management Series https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24866932-tether-supervision-contrast-ct-1200x628.png https://healthcarewiretexas.com/article/915165308-houston-truck-accident-personal-injury-law-firm-simmons-and-fletcher-named-to-national-top-experts-to-watch-in-2026 Healthcare Wire Texas en PressRelease 2026-05-26T12:49:37+00:00 Houston Truck Accident & Personal Injury Law Firm Simmons and Fletcher Named to National "Top Experts to Watch in 2026" https://healthcarewiretexas.com/article/915137190-plano-tx-physician-expands-long-covid-telemedicine-as-federal-clinics-close Healthcare Wire Texas en PressRelease 2026-05-26T10:07:19+00:00 Plano,TX Physician Expands Long COVID Telemedicine as Federal Clinics Close https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24866944-robert-groysman-with-patient-jp-800x1000.jpeg https://healthcarewiretexas.com/article/912999779-seniorcre-introduces-institutional-grade-investor-transparency-layer-for-senior-housing-operators-and-reits Healthcare Wire Texas en PressRelease 2026-05-26T10:00:00+00:00 SeniorCRE® Introduces Institutional-Grade Investor Transparency Layer for Senior Housing Operators and REITs https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24722263-seniorcre-2-1336x450.png https://healthcarewiretexas.com/article/915055114-innovotex-announces-company-overview-to-highlight-advancement-of-novo-111-and-macrocycle-drug-conjugate-platform Healthcare Wire Texas en PressRelease 2026-05-26T10:00:00+00:00 INNOVOTEX Announces Company Overview to Highlight Advancement of NOVO-111 and Macrocycle Drug Conjugate Platform https://healthcarewiretexas.com/article/914835668-tricelx-launches-xytrix-as-department-of-defense-collaboration-under-the-blast-overpressure-safety-act Healthcare Wire Texas en PressRelease 2026-05-26T09:30:00+00:00 TriCelX Launches XytriX™ as Department of Defense Collaboration Under the Blast Overpressure Safety Act https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24865765-military-1475x983.jpeg https://healthcarewiretexas.com/article/915183310-resolutions-from-zealand-pharma-s-extraordinary-general-meeting-2026 Healthcare Wire Texas en PressRelease 2026-05-26T14:00:00+00:00 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://healthcarewiretexas.com/article/915183409-ionetix-announces-approval-of-abbreviated-new-drug-application-for-gallium-ga-68-gozetotide-psma-11 Healthcare Wire Texas en PressRelease 2026-05-26T14:00:00+00:00 Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11) https://ml.globenewswire.com/media/Y2E3NjczN2UtMWY4YS00N2U0LTkxM2UtZTMwNTQwYmRlNTg5LTUwMDE2MzExMS0yMDI2LTA1LTI2LWVu/tiny/Ionetix-Corp-DE-.png https://healthcarewiretexas.com/article/915176688-cosmos-health-releases-2026-2029-guidance-targeting-200m-revenue-71m-gross-profit-and-44m-adjusted-ebitda-by-2029-building-an-innovative Healthcare Wire Texas en PressRelease 2026-05-26T13:34:16+00:00 Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation https://ml.globenewswire.com/media/94aa329d-a924-4f07-8eaf-d47e6da945fa/medium/cosmos-health-2029-guidance-summary-highlights.png https://healthcarewiretexas.com/article/915176682-medx-holdings-medh-reports-exceptional-q1-2026-financials-revenue-surges-expansion-on-track-and-ceo-to-speak-at-hemp-beverage-expo Healthcare Wire Texas en PressRelease 2026-05-26T13:32:23+00:00 MEDX HOLDINGS (MEDH) REPORTS EXCEPTIONAL Q1 2026 FINANCIALS: REVENUE SURGES, EXPANSION ON TRACK, AND CEO TO SPEAK AT HEMP BEVERAGE EXPO https://ml.globenewswire.com/media/995733cb-620f-4ea6-b204-8b5b5689df30/small/medx-logo-jpg.jpg https://healthcarewiretexas.com/article/915176622-catalyst-medtech-unveils-expanded-digirad-portfolio-imaging-innovation-showcase-and-long-term-support-strategy-at-snmmi-2026 Healthcare Wire Texas en PressRelease 2026-05-26T13:15:17+00:00 Catalyst MedTech Unveils Expanded Digirad® Portfolio, Imaging Innovation Showcase, and Long-Term Support Strategy at SNMMI 2026 https://ml.globenewswire.com/media/ZTk1MDgzY2YtYTI0OS00NzczLWE3MjgtMzNmM2MxMjQyNGQ4LTEzMTYxMTAtMjAyNi0wNS0yNi1lbg==/tiny/Catalyst-MedTech.png https://healthcarewiretexas.com/article/915176301-pacbio-sprq-nx-chemistry-now-shipping-worldwide-enabling-sub-300-hifi-genomes-for-large-scale-projects-and-ai-enhanced-sequencing Healthcare Wire Texas en PressRelease 2026-05-26T13:05:00+00:00 PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://healthcarewiretexas.com/article/915176613-editas-medicine-announces-pricing-of-up-to-319-4-million-public-offering Healthcare Wire Texas en PressRelease 2026-05-26T13:05:00+00:00 Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://healthcarewiretexas.com/article/915175644-santheras-aktion-re-stimmen-auf-der-heutigen-hauptversammlung-allen-antr-gen-des-verwaltungsrats-zu Healthcare Wire Texas en PressRelease 2026-05-26T13:00:00+00:00 Santheras Aktionäre stimmen auf der heutigen Hauptversammlung allen Anträgen des Verwaltungsrats zu https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://healthcarewiretexas.com/article/915175646-santhera-s-shareholders-approve-all-board-proposals-at-today-s-annual-general-meeting Healthcare Wire Texas en PressRelease 2026-05-26T13:00:00+00:00 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://healthcarewiretexas.com/article/915175660-asds-launches-enhanced-format-for-dermsurgery-digest-podcast Healthcare Wire Texas en PressRelease 2026-05-26T13:00:00+00:00 ASDS Launches Enhanced Format for DermSurgery Digest Podcast https://ml.globenewswire.com/media/Mjc1ZGI1MjAtYWYxMi00MTRlLTg3NGEtNzQyOTc2Mjk4MGI4LTEyMzM4NjMtMjAyNi0wNS0yNi1lbg==/tiny/American-Society-for-Dermatolo.png https://healthcarewiretexas.com/article/915168432-nodthera-announces-the-publication-and-presentation-of-cardiometabolic-clinical-data-supporting-the-potential-of-ruvonoflast-to-treat-inflammation-at Healthcare Wire Texas en PressRelease 2026-05-26T12:45:00+00:00 NodThera Announces the Publication and Presentation of Cardiometabolic Clinical Data Supporting the Potential of Ruvonoflast to Treat Inflammation at the Source https://ml.globenewswire.com/media/47e7b50f-0ca3-4bf3-8a6b-753432486e1c/small/nodthera-logo-full-color-rgb-high-png.png https://healthcarewiretexas.com/article/915168406-silexion-therapeutics-announces-1-for-10-reverse-share-split Healthcare Wire Texas en PressRelease 2026-05-26T12:30:00+00:00 Silexion Therapeutics Announces 1-for-10 Reverse Share Split https://ml-eu.globenewswire.com/media/1070dc42-db79-4712-af48-38ffbdf3b140/small/screenshot-2025-05-13-at-15-29-06-png.png https://healthcarewiretexas.com/article/915168428-abeona-therapeutics-announces-participation-in-upcoming-investor-conferences Healthcare Wire Texas en PressRelease 2026-05-26T12:30:00+00:00 Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://healthcarewiretexas.com/article/915168449-renovorx-announces-promising-pharmacokinetic-data-using-the-tamp-platform-presented-at-the-2026-asco-annual-meeting Healthcare Wire Texas en PressRelease 2026-05-26T12:30:00+00:00 RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://healthcarewiretexas.com/article/915168453-allogene-therapeutics-announces-participation-in-upcoming-investor-conferences Healthcare Wire Texas en PressRelease 2026-05-26T12:30:00+00:00 Allogene Therapeutics Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://healthcarewiretexas.com/article/915168800-microbot-medical-receives-its-first-international-regulatory-approval-for-the-commercialization-of-the-liberty-endovascular-robotic-system Healthcare Wire Texas en PressRelease 2026-05-26T12:30:00+00:00 Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://healthcarewiretexas.com/article/915168793-clearmind-medicine-announces-johns-hopkins-irb-approval-to-advance-cmnd-100-phase-i-ii-clinical-trial-to-the-next-parts Healthcare Wire Texas en PressRelease 2026-05-26T12:25:00+00:00 Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://healthcarewiretexas.com/article/915168813-aim-medical-robotics-announces-collaboration-agreement-with-siemens-healthineers-to-advance-mri-guided-robotic-neurosurgery Healthcare Wire Texas en PressRelease 2026-05-26T12:25:00+00:00 AiM Medical Robotics Announces Collaboration Agreement with Siemens Healthineers to Advance MRI-Guided Robotic Neurosurgery https://ml.globenewswire.com/media/ef9b4591-bf65-481f-a8aa-beeecb5b990d/medium/aim-medical-robotics.jpg https://healthcarewiretexas.com/article/915160490-60-degrees-pharmaceuticals-announces-early-enrollment-of-first-seasonal-patient-in-clinical-trial-of-tafenoquine-for-patients-hospitalized-with Healthcare Wire Texas en PressRelease 2026-05-26T12:02:00+00:00 60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis https://ml.globenewswire.com/media/c950cab5-27b1-476f-befc-4d92a7389fdd/small/60degrees-logo-rgb-logo-jpg.jpg https://healthcarewiretexas.com/article/915160166-vvt-med-announces-first-patients-treated-with-vvt-s-sclerosafe-system-in-italy Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 VVT Med Announces First Patients Treated with VVT’s ScleroSafe™ System in Italy https://ml-eu.globenewswire.com/media/7ee51e55-03a5-402b-887f-1c43066d7063/small/logo-303-png.png https://healthcarewiretexas.com/article/915160177-artios-announces-first-patient-dosed-in-randomized-phase-2-polka-study-evaluating-dna-polymerase-theta-inhibitor-art6043-in-gbrca-mutated Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Artios Announces First Patient Dosed in Randomized Phase 2 POLKA Study Evaluating DNA Polymerase Theta Inhibitor ART6043 in gBRCA-mutated HER2-Negative Breast Cancer https://ml-eu.globenewswire.com/media/c8fbd1a8-de4d-4316-a4ae-ce9fef6aca7d/small/artios-logo-nodscrptr-light-small-rgb-003-jpg.jpg https://healthcarewiretexas.com/article/915160189-nu-tek-biosciences-fuels-animal-free-raw-materials-revolution-joins-minnesota-pavilion-4507-at-bio-2026 Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Nu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026 https://ml.globenewswire.com/media/b076c8a8-2c93-47f1-94a7-bbf7451e8336/medium/soy-peptone.jpeg https://healthcarewiretexas.com/article/915160219-nu-tek-biosciences-treibt-die-revolution-im-bereich-tierfreier-rohstoffe-voran-teil-des-minnesota-pavilion-4507-auf-der-bio-2026 Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Nu-Tek BioSciences treibt die Revolution im Bereich tierfreier Rohstoffe voran, Teil des Minnesota Pavilion #4507 auf der BIO 2026 https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://healthcarewiretexas.com/article/915160221-nu-tek-biosciences-acc-l-re-la-r-volution-des-mati-res-premi-res-sans-origine-animale-et-rejoint-le-pavillon-du-minnesota-4507-au-salon-bio-2026 Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Nu-Tek BioSciences accélère la révolution des matières premières sans origine animale et rejoint le pavillon du Minnesota #4507 au salon BIO 2026 https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://healthcarewiretexas.com/article/915160227-esperion-presents-new-data-from-clear-outcomes-and-the-clear-path-phase-2-pediatric-study-at-the-european-atherosclerosis-society-congress-2026 Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026 https://ml.globenewswire.com/media/6af55bc4-856a-4007-b242-baeb422ba7e7/small/esperion-logo-primary-png.png https://healthcarewiretexas.com/article/915160242-biovie-announces-full-enrollment-of-the-address-lc-trial-of-bezisterim-for-the-treatment-of-neurological-symptoms-associated-with-long-covid Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID https://ml.globenewswire.com/media/f437d04b-c089-46eb-bca8-7ef64f68bc9b/small/biovie-logo-jpg.jpg https://healthcarewiretexas.com/article/915160260-mbx-biosciences-to-present-at-the-jefferies-2026-global-healthcare-conference-in-new-york-city Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City https://ml.globenewswire.com/media/5499b327-bce0-4a3f-96a7-04a38b68a99f/small/mbx-logos-final-full-jpg.jpg https://healthcarewiretexas.com/article/915160263-rhythm-pharmaceuticals-announces-participation-in-upcoming-investor-conferences Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://healthcarewiretexas.com/article/915160272-calidi-biotherapeutics-announces-online-abstract-acceptances-at-the-2026-asco-annual-meeting Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://healthcarewiretexas.com/article/915160368-lenz-therapeutics-to-participate-in-upcoming-investor-conferences Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 LENZ Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/e058841a-d17f-4fd7-b817-0b2c8e6cb656/small/lenz-png.png https://healthcarewiretexas.com/article/915160493-bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://healthcarewiretexas.com/article/915160504-pacira-biosciences-sets-the-record-straight-regarding-doma-s-misleading-statements-about-pacira-s-intellectual-property-strategy Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://healthcarewiretexas.com/article/915160543-cocrystal-pharma-announces-discovery-of-pan-viral-inhibitors-targeting-hantavirus-bunyavirus-and-influenza Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza https://ml.globenewswire.com/media/a5071a3a-c592-43ba-bfee-77c2867982ba/small/cocrystal-logo-final-highres-792x612-png.png https://healthcarewiretexas.com/article/915160551-humacyte-announces-presentation-at-vasa-meeting-of-research-highlighting-self-repair-of-atev-after-cannulation-for-dialysis-access Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://healthcarewiretexas.com/article/915160553-dar-bioscience-receives-nih-funding-award-notice-to-advance-dare-hpv-its-novel-investigational-treatment-for-persistent-high-risk-hpv-infection-the Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer https://ml.globenewswire.com/media/deaaf9ba-24cc-4909-ab8d-1982b8b4e650/small/darebioscience-primarylogo-02-vertical-reg-orangebrown-wtrad.png https://healthcarewiretexas.com/article/915160598-glucotrack-to-highlight-implantable-continuous-blood-glucose-monitoring-technology-at-the-american-diabetes-association-s-2026-scientific-sessions Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://healthcarewiretexas.com/article/915160616-progyny-inc-announces-share-repurchase-program Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Progyny, Inc. Announces Share Repurchase Program https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://healthcarewiretexas.com/article/915160766-rani-therapeutics-holdings-inc-announces-pricing-of-20-0-million-registered-direct-offering-of-class-a-common-stock-priced-at-the-market-under Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules https://ml.globenewswire.com/media/8ce7774c-3696-4aa1-8bcd-413805f0a642/small/rani-logo-jpg.jpg https://healthcarewiretexas.com/article/915160815-annovis-bio-regains-nyse-listing-compliance Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Annovis Bio Regains NYSE Listing Compliance https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://healthcarewiretexas.com/article/915160820-brain-cancer-canada-invests-50-000-in-promising-immunotherapy-breakthrough-targeting-one-of-the-most-aggressive-brain-tumours Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Brain Cancer Canada Invests $50,000 in Promising Immunotherapy Breakthrough Targeting One of the Most Aggressive Brain Tumours https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://healthcarewiretexas.com/article/915160924-gain-therapeutics-presents-positive-interim-data-from-phase-1b-clinical-study-of-gt-02287-at-3rd-international-gba1-meeting-2026 Healthcare Wire Texas en PressRelease 2026-05-26T12:00:00+00:00 Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026 https://ml.globenewswire.com/media/a9db1229-ee1e-4682-9900-5e1535759ca5/medium/figure-1.jpg https://healthcarewiretexas.com/article/915160765-kraig-biocraft-laboratories-smashes-production-targets-as-new-spider-silk-batch-surges-past-expectations Healthcare Wire Texas en PressRelease 2026-05-26T11:35:00+00:00 Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations https://ml.globenewswire.com/media/58ebfc72-e682-4d1d-bac8-69422f2dc514/medium/kraig-labs-exceed-spider-silk-production-yield-targets.jpg https://healthcarewiretexas.com/article/915160834-j-star-holding-subsidiary-receives-central-bank-of-taiwan-authorization-to-initiate-60-million-sovereign-backed-financing-framework-through Healthcare Wire Texas en PressRelease 2026-05-26T11:30:11+00:00 J-Star Holding Subsidiary Receives Central Bank of Taiwan Authorization to Initiate $60 Million Sovereign-Backed Financing Framework through Designated Banks for U.S. Solid-State Battery Expansion ($122.5 Million Project) https://ml.globenewswire.com/media/1a4c6faf-93be-4d28-a35f-1df9c4f0404e/small/j-star-logo-blue-transparent-png.png https://healthcarewiretexas.com/article/915160269-plus-cnside-diagnostic-platform-demonstrates-substantial-healthcare-cost-reduction-in-patients-with-leptomeningeal-metastases Healthcare Wire Texas en PressRelease 2026-05-26T11:30:00+00:00 Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://healthcarewiretexas.com/article/915160497-briacell-receives-positive-recommendation-from-data-safety-monitoring-board-dsmb-for-phase-3-study-in-metastatic-breast-cancer Healthcare Wire Texas en PressRelease 2026-05-26T11:30:00+00:00 BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://healthcarewiretexas.com/article/915160575-dyne-therapeutics-announces-submission-of-biologics-license-application-bla-to-u-s-fda-for-z-rostudirsen-in-exon-51-duchenne-muscular-dystrophy Healthcare Wire Texas en PressRelease 2026-05-26T11:30:00+00:00 Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD) https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://healthcarewiretexas.com/article/915160618-tg-therapeutics-announces-data-presentations-for-briumvi-at-the-2026-consortium-of-multiple-sclerosis-centers-annual-meeting Healthcare Wire Texas en PressRelease 2026-05-26T11:30:00+00:00 TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://healthcarewiretexas.com/article/915153329-kane-biotech-announces-the-oversubscription-and-closing-of-private-placement-offering Healthcare Wire Texas en PressRelease 2026-05-26T11:25:00+00:00 Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering https://ml.globenewswire.com/media/a2ad1d52-1d5a-425c-93de-45cc52c3784b/small/kane-logo-cropped-transbg-png.png https://healthcarewiretexas.com/article/915153448-nervgen-announces-positive-independent-blinded-biomechanical-gait-analyses-demonstrating-genuine-neural-recovery-with-nvg-291-in-phase-1b-2a-connect Healthcare Wire Texas en PressRelease 2026-05-26T11:15:00+00:00 NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png https://healthcarewiretexas.com/article/915153306-cartesian-therapeutics-secures-up-to-150-million-of-non-dilutive-financing-from-k2-healthventures-and-expects-topline-data-from-the-phase-3-aurora Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027 https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://healthcarewiretexas.com/article/915153314-olema-oncology-announces-clinical-trial-collaboration-and-supply-agreement-with-bayer-to-evaluate-op-3136-in-combination-with-nubeqa-darolutamide Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://healthcarewiretexas.com/article/915153321-outlook-therapeutics-wins-appeal-following-formal-dispute-resolution-process-for-ons-5010-lytenava-bevacizumab-vikg Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg) https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://healthcarewiretexas.com/article/915153326-tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-the-professional-society Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://healthcarewiretexas.com/article/915153348-jade-biosciences-announces-first-participant-dosed-in-phase-2-juniper-clinical-trial-of-jade101-in-iga-nephropathy Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://healthcarewiretexas.com/article/915153385-diasome-to-present-phase-2b-results-from-opti-2-trial-evaluating-hdv-insulin-lispro-in-type-1-diabetes-at-ada-86th-scientific-sessions Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions https://ml.globenewswire.com/media/MGZiNzE4NTItZTAyMi00ODRkLTk3MGEtMThmM2RmZmVmNjBkLTEzMjM0MzctMjAyNi0wNS0yNi1lbg==/tiny/Diasome.png https://healthcarewiretexas.com/article/915153428-spectral-ai-receives-fda-de-novo-clearance-for-deepview-system-for-burn-indication Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication https://ml.globenewswire.com/media/9b69755f-81d5-424f-acfe-73cdeb50cc85/medium/deepview-system-caption.jpeg https://healthcarewiretexas.com/article/915153437-corbus-pharmaceuticals-reports-updated-crb-701-phase-1-2-clinical-data-demonstrating-robust-activity-in-2l-oropharyngeal-and-cervical-cancers Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://healthcarewiretexas.com/article/915153443-climb-bio-to-present-on-clym116-and-budoprutug-programs-at-european-renal-association-era-congress-2026 Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026 https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://healthcarewiretexas.com/article/915153470-cullinan-therapeutics-to-host-immunology-day-to-showcase-promising-initial-clinical-data-in-autoimmune-diseases-for-cln-978-a-cd19-t-cell-engager Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Cullinan Therapeutics to Host Immunology Day to Showcase Promising Initial Clinical Data in Autoimmune Diseases for CLN-978, a CD19 T Cell Engager, and Velinotamig, a BCMA T Cell Engager https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png https://healthcarewiretexas.com/article/915153472-axsome-therapeutics-presents-new-auvelity-data-in-major-depressive-disorder-at-the-american-society-of-clinical-psychopharmacology-ascp-2026-annual Healthcare Wire Texas en PressRelease 2026-05-26T11:00:00+00:00 Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting https://ml.globenewswire.com/media/1186f248-bfb6-4258-a391-f2ffd94c5d76/small/axsome-r-morpheus-logo-pos-rgb-png.png https://healthcarewiretexas.com/article/915145928-curevo-to-be-acquired-by-lilly-to-advance-next-generation-shingles-prevention Healthcare Wire Texas en PressRelease 2026-05-26T10:45:00+00:00 Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention https://ml.globenewswire.com/media/002a741b-3d3a-4ba1-b93e-635fdfcce0a6/small/curevo-large-png.png https://healthcarewiretexas.com/article/915145852-nxera-s-president-ceo-to-participate-in-a-fireside-chat-at-the-jefferies-new-york-healthcare-conference-2026 Healthcare Wire Texas en PressRelease 2026-05-26T10:22:27+00:00 Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026 https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://healthcarewiretexas.com/article/915145961-editas-medicine-announces-proposed-public-offering Healthcare Wire Texas en PressRelease 2026-05-26T10:15:03+00:00 Editas Medicine Announces Proposed Public Offering https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://healthcarewiretexas.com/article/915139250-kura-oncology-reports-strong-clinical-activity-and-safety-with-darlifarnib-adagrasib-in-kras-g12c-mutated-solid-tumors Healthcare Wire Texas en PressRelease 2026-05-26T10:02:00+00:00 Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors https://ml.globenewswire.com/media/52aa1f06-6701-4a4b-950a-526765c4f974/medium/best-percent-change-in-target-lesion-size-pdac-nsclc-and-crc.png https://healthcarewiretexas.com/article/915139253-editas-medicine-presents-edit-401-preclinical-data-demonstrating-robust-reductions-in-ldl-c-lp-a-and-apob-in-non-human-primates-at-the-94th Healthcare Wire Texas en PressRelease 2026-05-26T10:01:00+00:00 Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://healthcarewiretexas.com/article/915139258-new-study-finds-over-a-third-of-young-men-at-risk-of-gambling-related-harm-fathers-disproportionately-affected Healthcare Wire Texas en PressRelease 2026-05-26T10:00:00+00:00 New study finds over a third of young men at risk of gambling related harm; fathers disproportionately affected https://ml.globenewswire.com/media/f2f6b477-dccb-443c-b682-b25ec93d8262/medium/gambling-related-harm-tied-to-anxiety-depression.png https://healthcarewiretexas.com/article/915122622-metriopharm-ag-prof-dr-med-j-rgen-braun-appointed-as-new-member-of-the-scientific-advisory-board Healthcare Wire Texas en PressRelease 2026-05-26T08:00:00+00:00 MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board https://ml-eu.globenewswire.com/media/MWU5NGFlNjEtNGEyZi00ZDA5LTkzYjUtODkwZDYzYTRhZjEzLTEwMzc0NTQtMjAyNi0wNS0yNi1lbg==/tiny/AKAMPION.png https://healthcarewiretexas.com/article/915122624-metriopharm-ag-prof-dr-med-j-rgen-braun-wird-neues-mitglied-des-wissenschaftlichen-beirats Healthcare Wire Texas en PressRelease 2026-05-26T08:00:00+00:00 MetrioPharm AG: Prof. Dr. med. Jürgen Braun wird neues Mitglied des wissenschaftlichen Beirats https://ml-eu.globenewswire.com/media/MWU5NGFlNjEtNGEyZi00ZDA5LTkzYjUtODkwZDYzYTRhZjEzLTEwMzc0NTQtMjAyNi0wNS0yNi1kZQ==/tiny/AKAMPION.png https://healthcarewiretexas.com/article/915107347-tilray-medical-brings-global-medical-cannabis-expertise-to-cannabis-europa-london-2026 Healthcare Wire Texas en PressRelease 2026-05-26T06:00:00+00:00 Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026 https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://healthcarewiretexas.com/article/915107344-onward-medical-reports-first-quarter-2026-results-with-strong-commercial-momentum-and-key-clinical-milestones Healthcare Wire Texas en PressRelease 2026-05-26T05:30:00+00:00 ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://healthcarewiretexas.com/article/915088559-rapid-nutrition-completes-a-2-million-australian-wellness-platform-transaction Healthcare Wire Texas en PressRelease 2026-05-26T03:05:00+00:00 Rapid Nutrition Completes A$2 Million Australian Wellness Platform Transaction https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://healthcarewiretexas.com/article/915072296-maple-tree-counselling-expands-evidence-based-therapy-services-across-hong-kong-and-australia-with-somatic-therapy-emdr-and-cbt-approaches Healthcare Wire Texas en PressRelease 2026-05-26T01:00:00+00:00 Maple Tree Counselling Expands Evidence-Based Therapy Services Across Hong Kong and Australia With Somatic Therapy, EMDR and CBT Approaches https://ml.globenewswire.com/media/7adc41fa-d7d7-4adf-ba7b-d16c3e25b8a4/medium/maple-tree-counselling-hk.png https://healthcarewiretexas.com/article/915061359-agc-biologics-to-manufacture-teikoku-seiyaku-s-rhmmp-7-drug-substance Healthcare Wire Texas en PressRelease 2026-05-26T00:00:00+00:00 AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance https://ml.globenewswire.com/media/a367ab3c-59c3-4f88-908e-776b0f0d08ba/medium/gmp-manufacturing-at-the-agc-biologics-chiba-facility.jpg https://healthcarewiretexas.com/article/915061375-agc-rhmmp-7 Healthcare Wire Texas en PressRelease 2026-05-26T00:00:00+00:00 AGCバイオロジクス、帝國製薬のrhMMP-7原薬を製造へ https://ml.globenewswire.com/media/10608348-8d8c-4d97-ab9c-12db5b8b015d/small/rgb-primary-agc-biologics-logo-with-tagline-png.png https://healthcarewiretexas.com/article/915061386-agc-biologics-teikoku-seiyaku-rhmmp-7 Healthcare Wire Texas en PressRelease 2026-05-26T00:00:00+00:00 AGC Biologics 將為 Teikoku Seiyaku 生產 rhMMP-7 原料藥 https://ml.globenewswire.com/media/10608348-8d8c-4d97-ab9c-12db5b8b015d/small/rgb-primary-agc-biologics-logo-with-tagline-png.png https://healthcarewiretexas.com/article/915061394-agc-biologics-teikoku-seiyaku-co-ltd-rhmmp-7 Healthcare Wire Texas en PressRelease 2026-05-26T00:00:00+00:00 AGC Biologics, 글로벌 제약기업인 테이코쿠 제약 (Teikoku Seiyaku Co., Ltd. )의 rhMMP-7 원료의약품 생산 맡는다 https://ml.globenewswire.com/media/10608348-8d8c-4d97-ab9c-12db5b8b015d/small/rgb-primary-agc-biologics-logo-with-tagline-png.png https://healthcarewiretexas.com/article/915061396-agc-biologics-akan-menghasilkan-bahan-aktif-farmaseutikal-ubat-rhmmp-7-teikoku-seiyaku Healthcare Wire Texas en PressRelease 2026-05-26T00:00:00+00:00 AGC Biologics akan Menghasilkan Bahan Aktif Farmaseutikal Ubat rhMMP-7 Teikoku Seiyaku https://ml.globenewswire.com/media/10608348-8d8c-4d97-ab9c-12db5b8b015d/small/rgb-primary-agc-biologics-logo-with-tagline-png.png https://healthcarewiretexas.com/article/915061402-agc-biologics-teikoku-seiyaku-rhmmp-7 Healthcare Wire Texas en PressRelease 2026-05-26T00:00:00+00:00 AGC Biologics 将为 Teikoku Seiyaku 生产 rhMMP-7 原料药 https://ml.globenewswire.com/media/10608348-8d8c-4d97-ab9c-12db5b8b015d/small/rgb-primary-agc-biologics-logo-with-tagline-png.png https://healthcarewiretexas.com/article/915043917-hormify-customers-report-95-support-satisfaction-how-the-brand-is-setting-a-new-standard-in-supplement-customer-care Healthcare Wire Texas en PressRelease 2026-05-25T21:48:14+00:00 Hormify Customers Report 95% Support Satisfaction: How the Brand Is Setting a New Standard in Supplement Customer Care https://ml.globenewswire.com/media/c7f49145-ba0d-482a-841e-56a701bb14d2/small/555-jpg.jpg https://healthcarewiretexas.com/article/915043913-no-hidden-enrollments-no-refund-runaround-how-hormify-is-raising-the-bar-for-supplement-billing Healthcare Wire Texas en PressRelease 2026-05-25T21:47:03+00:00 No Hidden Enrollments, No Refund Runaround: How Hormify Is Raising the Bar for Supplement Billing https://ml.globenewswire.com/media/c7f49145-ba0d-482a-841e-56a701bb14d2/small/555-jpg.jpg https://healthcarewiretexas.com/article/914991134-ab-science-announces-that-its-stock-continues-to-be-covered-by-maxim-group-with-a-target-price-of-4-00-per-share Healthcare Wire Texas en PressRelease 2026-05-25T16:06:43+00:00 AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://healthcarewiretexas.com/article/914991136-ab-science-annonce-que-le-titre-ab-science-continue-d-tre-couvert-par-maxim-group-avec-un-objectif-de-cours-de-4-00-par-action Healthcare Wire Texas en PressRelease 2026-05-25T16:06:43+00:00 AB Science annonce que le titre AB Science continue d’être couvert par Maxim Group, avec un objectif de cours de 4,00 € par action https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://healthcarewiretexas.com/article/914986444-genfit-forte-pr-sence-scientifique-et-strat-gique-au-congr-s-easl-2026 Healthcare Wire Texas en PressRelease 2026-05-25T16:00:00+00:00 GENFIT : Forte présence scientifique et stratégique au Congrès EASL 2026   https://ml-eu.globenewswire.com/media/M2NlZTAxY2EtMmY5Ni00YzdlLThhZTYtM2JhN2JlZDg0ZjJjLTEwMTEyNjgtMjAyNi0wNS0yNS1mcg==/tiny/GENFIT-S-A-.png https://healthcarewiretexas.com/article/914986448-genfit-highlights-broad-scientific-and-strategic-presence-at-easl-congress-2026 Healthcare Wire Texas en PressRelease 2026-05-25T16:00:00+00:00 GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026   https://ml-eu.globenewswire.com/media/M2NlZTAxY2EtMmY5Ni00YzdlLThhZTYtM2JhN2JlZDg0ZjJjLTEwMTEyNjgtMjAyNi0wNS0yNS1lbg==/tiny/GENFIT-S-A-.png https://healthcarewiretexas.com/article/914977478-resolution-therapeutics-congratulates-university-of-edinburgh-on-positive-4-year-match-trial-data-on-rmt-in-liver-cirrhosis Healthcare Wire Texas en PressRelease 2026-05-25T15:00:00+00:00 Resolution Therapeutics congratulates University of Edinburgh on positive 4-year MATCH trial data on RMT in liver cirrhosis https://ml-eu.globenewswire.com/media/9482740b-de8b-45a4-b278-7f5f9c3797c0/small/high-resolution-logo-png.png https://healthcarewiretexas.com/article/914977495-seoprofy-heads-to-barcelona-as-a-sponsor-of-shoptalk-europe-2026 Healthcare Wire Texas en PressRelease 2026-05-25T15:00:00+00:00 SeoProfy heads to Barcelona as a sponsor of Shoptalk Europe 2026 https://ml.globenewswire.com/media/8de4f9a6-184d-4963-a451-71580cd5a006/small/logo-jpg.jpg https://healthcarewiretexas.com/article/914969082-ph-wellness-opens-addiction-treatment-center-in-lebanon-tennessee Healthcare Wire Texas en PressRelease 2026-05-25T14:00:00+00:00 pH Wellness opens addiction treatment center in Lebanon, Tennessee https://pressranger.s3.us-west-1.amazonaws.com/3299719/ph29.jpg https://healthcarewiretexas.com/article/914952955-media-advisory-entire-train-cars-of-local-residents-head-to-toronto-for-giant-march-to-demand-doug-ford-stop-his-unprecedented-privatization-of-our Healthcare Wire Texas en PressRelease 2026-05-25T12:00:00+00:00 MEDIA ADVISORY -- Entire train cars of local residents head to Toronto for giant march to demand Doug Ford stop his unprecedented privatization of our public hospital services https://ml.globenewswire.com/media/fdd00e9f-f066-4244-85e8-d12e6d1b760c/small/screen-shot-2023-09-14-at-1-49-15-pm-png.png https://healthcarewiretexas.com/article/914949008-vireo-growth-inc-to-acquire-bridgewell-agribusiness-llc Healthcare Wire Texas en PressRelease 2026-05-25T11:30:00+00:00 Vireo Growth Inc. to Acquire Bridgewell Agribusiness LLC https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://healthcarewiretexas.com/article/914944698-grey-matters-improves-warrant-terms-of-private-placement Healthcare Wire Texas en PressRelease 2026-05-25T11:00:00+00:00 Grey Matters Improves Warrant Terms of Private Placement https://ml.globenewswire.com/media/7c6d355f-67f3-42bb-8eeb-dc06a8c0cdd1/small/grey-matters-health-jpg.jpg https://healthcarewiretexas.com/article/914913097-the-hidden-impact-of-veterinary-care-new-insights-from-a-global-survey-of-veterinarians Healthcare Wire Texas en PressRelease 2026-05-25T07:00:00+00:00 The hidden impact of veterinary care: new insights from a global survey of veterinarians https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://healthcarewiretexas.com/article/914792908-select-bestselling-authors-from-the-gifts-of-pain-celebrate-mental-health-awareness-month-with-new-spanish-version Healthcare Wire Texas en PressRelease 2026-05-24T15:37:23+00:00 Select Bestselling Authors from The Gifts of Pain Celebrate Mental Health Awareness Month with New Spanish Version https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24865667-los-dones-del-dolor-historias-4000x2667.png